21 Oct, 2015
Maria Severina, HyTest Managing Director, Regional Winner of the EY Entrepreneur of the Year 2015 Competition
On the 19th October Maria Severina was chosen as a regional winner of West Finland in the category production.
Read more
29 Sep, 2015
White paper: Natriuretic peptides, heart failure and LCZ696
The newly FDA-approved heart failure drug (Entresto®) has caused significant excitement as the clinical studies have shown considerably better therapy outcomes for patients suffering from heart failure.
Read more
01 Sep, 2015
Strong Growth in Sales During the First Half of 2015
HyTest was able to continue its strong growth during the first half of 2015. Consolidated revenue grew to 9.2 million euros, which represented an increase of 18% compared to the first half of the previous year.
Read more
23 Jun, 2015
HyTest SES-BNP and IGFBP-4 Patents
We are delighted to announce the news that HyTest has been granted a patent in the United States for SES-BNP technology and IGFBP-4 fragments in Finland, France, Germany, Sweden and the United Kingdom.
Read more
17 Jun, 2015
New Veterinary Antibodies and Antigens Available
Our new MAbs and antigens allow detection of CRP in dogs and SAA in dogs, cats and horses.
Read more
21 May, 2015
Meet HyTest Team at AACC 2015 Atlanta
In July 26-30 HyTest will be participating the 2015 AACC Annual Meeting & Clinical Lab Expo
Read more
05 May, 2015
HyTest Financial Results 2014 - Strong Growth Continues
HyTest has been growing steadily throughout its 20 year history and 2014 was no exception. HyTest’s revenue grew to 16.3 million euros.
Read more
16 Apr, 2015
HyTest Participates in ACVIM 2015 Veterinary Conference
Forum of American College of Veterinary Internal Medicine is held in Indianapolis in June 2015. You are welcome to visit our booth #230 on June 4-5.
Read more
15 Apr, 2015
First Online Order -15%
Limited time offer: save 15% on your first online order!
Read more
29 Jan, 2015
HyTest attends CACLP and IVD Summit in China
HyTest participates the 6th Annual IVD Summit 2015 in Shenzhen, China on March 12-13, 2015 and also the 12th China Association of Clinical Laboratory Practice Expo held in Xiamen, Fujian, 18 – 20, March.
Read more
05 Dec, 2014
The HyTest Cardiac Marker Award winner has been announced
Winner of the grand prize, $20,000 is Professor Paul Collinson from St. George’s, University of London and St. George’s Healthcare NHS Trust. Congratulations!
Read more
06 Nov, 2014
HyTest attending Medica trade fair in November 2014
HyTest participates in Medica exhibition in November 12th - 15th.
Read more
03 Oct, 2014
HyTest receives Achiever Certificate 2014
Companies receiving Achiever certification are stable businesses with solid growth, good financial results and profitability.
Read more
16 Sep, 2014
HyTest’s 20th anniversary year starts with strong growth in sales
During the first half of the year, HyTest’s consolidated sales were 7.8 million euros and year-on-year sales grew by 24%. Group operating profit also saw significant growth, reaching 3.4 million euros.
Read more
09 Jul, 2014
HyTest will be attending AACC 2014 in Chicago on July 29-31
HyTest participates in AACC 2014 Clinical Lab Expo Exhibition in Chicago on July 29-31. You are welcome to visit our booth #3631at any time. Our team is looking forward to see you there!
Read more
27 May, 2014
HyTest attends ISACP in Copenhagen
HyTest will be present at ISACP 2014 Veterinary Conference. The ISACP will be held on 25-29 of June 2014 in Copenhagen, Denmark.
Read more
11 Apr, 2014
HyTest fiscal year 2013 - a record level of operating profit
HyTest turns 20 and reaches a record level of operating profit. While the previous year’s growth figures were not achieved, sales grew steadily throughout the fiscal year.
Read more
26 Jan, 2014
HyTest attends IVD Summit and CACLP in China
This March HyTest will be present at this year’s IVD summit and CACLP exhibition. The 11th CACLP exhibition will be held on 5-7 March in Hefei and the 5th IVD Summit will be held in Xiamen on 8-9 March.
Read more
11 Dec, 2013
Mercodia commercializes HyTest's proprietary IGFBP-4 fragments technology
Mercodia commercializes HyTest's proprietary IGFBP-4 fragments technology; A novel risk marker for cardiovascular disease
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!